Jinming Yang

20.2k total citations · 1 hit paper
190 papers, 7.8k citations indexed

About

Jinming Yang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Jinming Yang has authored 190 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 70 papers in Oncology and 47 papers in Immunology. Recurrent topics in Jinming Yang's work include Autophagy in Disease and Therapy (24 papers), Immunotherapy and Immune Responses (17 papers) and Immune Cell Function and Interaction (16 papers). Jinming Yang is often cited by papers focused on Autophagy in Disease and Therapy (24 papers), Immunotherapy and Immune Responses (17 papers) and Immune Cell Function and Interaction (16 papers). Jinming Yang collaborates with scholars based in United States, China and Canada. Jinming Yang's co-authors include William N. Hait, Ann Richmond, Xingcong Ren, Yan Cheng, Chang‐Gong Liu, Hua Zhu, Xisha Chen, Yan Cheng, Daniel Medina and Yidi Guan and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Advanced Materials.

In The Last Decade

Jinming Yang

181 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DNA Repair Pathways in Cancer Therapy and Resistance

2021 248 citations Lanya Li, Jinming Yang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jinming Yang United States	51	4.7k	2.5k	2.1k	1.3k	1.2k	190	7.8k
Ingrid Herr Germany	50	6.6k 1.4×	3.0k 1.2×	2.1k 1.0×	1.8k 1.3×	1.1k 0.9×	139	10.2k
Nathan R. Wall United States	37	5.1k 1.1×	1.8k 0.7×	1.4k 0.7×	1.0k 0.8×	697 0.6×	99	7.5k
Jin Cheng China	43	4.2k 0.9×	2.1k 0.9×	1.4k 0.6×	980 0.7×	903 0.8×	118	7.5k
Frank A.E. Kruyt Netherlands	50	5.7k 1.2×	2.3k 0.9×	1.7k 0.8×	888 0.7×	739 0.6×	140	7.9k
Laura Senovilla France	44	4.0k 0.8×	3.2k 1.3×	1.3k 0.6×	2.4k 1.8×	992 0.9×	86	8.4k
Chuan‐Yuan Li United States	40	3.6k 0.8×	1.6k 0.6×	1.4k 0.7×	1.3k 1.0×	533 0.5×	115	6.0k
Gen Sheng Wu United States	47	5.0k 1.1×	2.1k 0.8×	1.4k 0.7×	1.1k 0.8×	601 0.5×	87	6.6k
Gerardo Ferbeyre Canada	43	5.5k 1.2×	2.0k 0.8×	1.3k 0.6×	1.1k 0.8×	521 0.4×	122	7.8k
Alfred S.L. Cheng Hong Kong	51	5.4k 1.1×	1.4k 0.6×	2.5k 1.2×	867 0.6×	1.0k 0.9×	146	8.2k
Karen Blyth United Kingdom	43	4.7k 1.0×	1.9k 0.7×	2.2k 1.0×	939 0.7×	406 0.3×	134	7.0k

Countries citing papers authored by Jinming Yang

Since Specialization

Citations

This map shows the geographic impact of Jinming Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinming Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinming Yang more than expected).

Fields of papers citing papers by Jinming Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinming Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinming Yang. The network helps show where Jinming Yang may publish in the future.

Co-authorship network of co-authors of Jinming Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Jinming Yang. A scholar is included among the top collaborators of Jinming Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinming Yang. Jinming Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fan, Jiawei, Tien-Chin Chang, Yao Shen, et al.. (2025). Inhibition of Glutamine Metabolism Attenuates Tumor Progression Through Remodeling of the Macrophage Immune Microenvironment. Advanced Biology. 9(10). e00738–e00738. 2 indexed citations

Yang, Jinming, et al.. (2024). Carbon monoxide-releasing Vehicle CO@TPyP-FeMOFs modulating macrophages phenotype in inflammatory wound healing. Nitric Oxide. 149. 49–59. 2 indexed citations

Yang, Jinming, et al.. (2024). Treatment of iliac arteriovenous malformation associated with trisomy 21: a case report. Journal of Cardiothoracic Surgery. 19(1). 594–594.

Yang, Yue, Daizong Cui, He Wang, et al.. (2024). The cytotoxicity of photoexcited CdS in an E. coli-CdS hybrid system and the roles of the sacrificial agent to reduce this toxic effect. Environmental Research. 267. 120700–120700.

Zhu, Rongfeng, Sheng Tian, Xiaobao Zhao, et al.. (2023). Design and Characterization of a Novel eEF2K Degrader with Potent Therapeutic Efficacy Against Triple‐Negative Breast Cancer. Advanced Science. 11(5). e2305035–e2305035. 12 indexed citations

Li, Lanya, et al.. (2023). Role and clinical implication of autophagy in COVID-19. Virology Journal. 20(1). 125–125. 8 indexed citations

Wan, Quan, Qing Wang, Zhenzhong Chen, et al.. (2022). TRAF4 Maintains Deubiquitination of Caveolin-1 to Drive Glioblastoma Stemness and Temozolomide Resistance. Cancer Research. 82(19). 3573–3587. 25 indexed citations

Liu, Zhendong, et al.. (2021). Expression and clinical significance of UBE2V1 in cervical cancer. Biochemistry and Biophysics Reports. 28. 101108–101108. 2 indexed citations

Scalise, Carly Bess, Caroline A. Nebhan, Jinming Yang, et al.. (2020). Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy. Breast Cancer Research and Treatment. 184(2). 357–364. 6 indexed citations

10.

Yang, Jinming, Chi Yan, Anna E. Vilgelm, et al.. (2020). Targeted Deletion of CXCR2 in Myeloid Cells Alters the Tumor Immune Environment to Improve Antitumor Immunity. Cancer Immunology Research. 9(2). 200–213. 56 indexed citations

11.

Vilgelm, Anna E., Nabil Saleh, Rebecca L. Shattuck-Brandt, et al.. (2019). MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21. Science Translational Medicine. 11(505). 88 indexed citations

12.

Yang, Jinming, Amrendra Kumar, Anna E. Vilgelm, et al.. (2018). Loss of CXCR4 in Myeloid Cells Enhances Antitumor Immunity and Reduces Melanoma Growth through NK Cell and FASL Mechanisms. Cancer Immunology Research. 6(10). 1186–1198. 57 indexed citations

13.

Sai, Jiqing, Philip Owens, Sergey V. Novitskiy, et al.. (2016). PI3K Inhibition Reduces Mammary Tumor Growth and Facilitates Antitumor Immunity and Anti-PD1 Responses. Clinical Cancer Research. 23(13). 3371–3384. 89 indexed citations

14.

Yang, Jinming, Oriana E. Hawkins, Whitney Barham, et al.. (2014). Myeloid IKKβ Promotes Antitumor Immunity by Modulating CCL11 and the Innate Immune Response. Cancer Research. 74(24). 7274–7284. 36 indexed citations

15.

Zhang, Yi, Yan Cheng, Xingcong Ren, et al.. (2012). Dysfunction of Nucleus Accumbens-1 Activates Cellular Senescence and Inhibits Tumor Cell Proliferation and Oncogenesis. Cancer Research. 72(16). 4262–4275. 29 indexed citations

16.

Yang, Jinming, Sara Kantrow, Jiqing Sai, et al.. (2012). Ikk4a/Arf Inactivation with Activation of the NF-κB/IL-6 Pathway Is Sufficient to Drive the Development and Growth of Angiosarcoma. Cancer Research. 72(18). 4682–4695. 30 indexed citations

17.

Cheng, Yan, Yi Zhang, Li Zhang, et al.. (2011). MK-2206, a Novel Allosteric Inhibitor of Akt, Synergizes with Gefitinib against Malignant Glioma via Modulating Both Autophagy and Apoptosis. Molecular Cancer Therapeutics. 11(1). 154–164. 113 indexed citations

18.

Cheng, Yan, Xingcong Ren, Yi Zhang, et al.. (2011). eEF-2 Kinase Dictates Cross-Talk between Autophagy and Apoptosis Induced by Akt Inhibition, Thereby Modulating Cytotoxicity of Novel Akt Inhibitor MK-2206. Cancer Research. 71(7). 2654–2663. 124 indexed citations

19.

Yang, Jinming, et al.. (2007). Effect of a Single Nucleotide Polymorphism in the Murine Double Minute 2 Promoter (SNP309) on the Sensitivity to Topoisomerase II–Targeting Drugs. Cancer Research. 67(12). 5831–5839. 43 indexed citations

20.

Yang, Jinming, et al.. (2007). Systemic Targeting Inhibitor of κB Kinase Inhibits Melanoma Tumor Growth. Cancer Research. 67(7). 3127–3134. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact